MedTrace Logo

6-month Clinical Investigation Assessing the Efficacy of an Antimicrobial Mouthrinse in Reducing Established Plaque and Improving Gum Health

NCT07414173 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-02-17

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the clinical efficacy of an antimicrobial mouthrinse, with a particular focus on its effect on established plaque and the improvement of gum health.

Participants will:

* Brush and rinse twice a day with the designated products for 6 months
* Visit the clinic once every 3 months after baseline for reassessment.

Conditions

  • Gingivitis
  • Dental Plaque Accumulation

Interventions

OTHER

Test Mouthrinse

Test Mouthrinse: 0.0553% NaF (250 ppm Fluoride), Amine and 0.2% Zinc Lactate dihydrate

OTHER

Control Mouthrinse

Control Mouthrinse: 0.0553% NaF(250 ppm Fluoride)

Sponsors & Collaborators

  • Colgate Palmolive

    lead INDUSTRY

Principal Investigators

  • Eva-Maria Axmann · SGS proderm GmbH

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-28
Primary Completion
2026-09-30
Completion
2026-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07414173 on ClinicalTrials.gov